South San Francisco, California
We have an opening for a talented Postdoctoral Fellow to join the laboratory of Dr. Andrey Shaw in the Oncology Department at Genentech. The focus of the lab is to use structural, biochemical and cellular approaches to study MAPK signaling in cancer with a specific focus on the RAF kinases and the KSR pseudokinases. The successful candidate will have experience in protein purification, protein characterization, enzymology and characterization of protein-protein interactions as well as experience in cellular experiments (tissue culture, IP western and mass spec, signaling experiments, siRNA/CRISPR) using mammalian tumor cells. The lab projects are focused on building mechanistic hypotheses using biochemical experiments/ approaches and testing those hypotheses in relevant cellular models. Experience with structural biology and biophysical methods including structural determination, mass spectrometry, fluorescence and microscopic based approaches to study protein-protein interactions in cells is also desirable. The lab has access to state of the art mass spectrometry facilities, a structural biology group, automation for high-throughput screening, access to libraries of small molecule compounds as well as access to in vivo mouse model development.
The qualified individual will possess a Ph.D. in Biochemistry, Cell Biology or related field with a solid publication record. Excellent communication and writing skills as well as a track record of working in highly collaborative environments is a must.
Relevant Lab Publications:
More information about the Shaw Lab:
More information about the Genentech Postdoctoral Program:
Genentech, a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. To solve the world's most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Diversity and Inclusion (D&I) are critical to the success of our company and our impact on society. We believe that by championing diversity of background, thought and experience, we can foster a sense of belonging and provide an environment where every employee feels valued, included, and able to contribute their best for the patients we serve. We’re focused on attracting, retaining, developing and advancing our people to their full potential by rewarding bold ways of thinking and integrating inclusive behaviors into every aspect of our work.
The next step is yours. To apply today, click on the "Apply for this job" button.
Genentech is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status. For more information about equal employment opportunity, visit our Genentech Careers page.
These are our stories - stories of the obstacles and opportunities that define and celebrate the unique people at Genentech.